Below are draft social media posts tailored for different professional audiences based on this application:
📢
: Intravenous or subcutaneous, with IV recommended for hemodialysis patients. 125545
Approved under BLA , this biosimilar offers flexible dosing schedules for various patient needs: Adult CKD : 50 to 100 units/kg 3 times weekly. Pediatric CKD : 50 units/kg 3 times weekly. Below are draft social media posts tailored for